Last reviewed · How we verify

NCT04171076

Transcutaneous Spinal Cord Stimulation for Parkinson Disease

Status unknown NA Last updated 20 November 2019
What this trial tests

NA trial testing Transcutaneous spinal cord stimulation in Parkinson Disease in 5 participants. Status unknown.

Timeline
15 October 2019
Primary endpoint
15 November 2019
30 November 2019

Quick facts

Lead sponsorUniversity of Sao Paulo General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date15 October 2019
Primary completion15 November 2019
Estimated completion30 November 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo General Hospital

Who can join

18 and older, any sex, with Parkinson Disease or Gait, Rigid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal cord stimulation has been used to treat gait problems in Parkinson's disease, with positive results along some studies. The use of non-invasive stimulation can be an alternative to stimulate the spinal corn.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcutaneous spinal cord stimulation

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of Sao Paulo General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04171076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing